Skip to main content

Advertisement

SpringerLink
Log in

The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Aim

Cholangitis is the most common infectious complication of ERCP. In vitro studies showed that addition of aminoglycosides to contrast medium was effective in reducing cholangitis but the results of clinical trials are conflicting. We studied the effect of adding gentamicin to contrast medium in reducing the rate of post-ERCP cholangitis in patients with non-calculous obstructive jaundice.

Methods

All patients with non-calculous obstructive jaundice who underwent endoscopic biliary stenting at the Shariati Hospital, Tehran, between December 2009 and October 2010 were enrolled in the study. Gentamicin (10 mg) or distilled water was added to each 10 cc contrast medium during ERCP. Intravenous antibiotics were administered before and after the procedure in all patients. After ERCP and stent deployment, patients were followed for 72 h for symptoms and signs of cholangitis.

Results

A total of 114 patients were eligible for the study. Of these, 57 patients were included in each group. Cholangiocarcinoma was the most prevalent diagnosis. The obstruction was relieved in all patients by stenting. Five patients in each group (8.8 %) developed cholangitis. There was no significant difference in the incidence of cholangitis between the two groups (p = 1.000).

Conclusions

With adequate drainage of the obstructed biliary tract by proper stenting, adding gentamicin to contrast media had no significant effect on incidence of post-ERCP cholangitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Loperfido S, Caroli A. Post-ERCP septic complications. In: UpToDate, Rose, BD, eds. Uptodate, Inc., Waltham, MA; 2009. 17.3

  2. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101:1374–81.

    PubMed  CAS  Google Scholar 

  3. Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc. 1988;34:95–101.

    Article  PubMed  CAS  Google Scholar 

  4. Rerknimitr R, Attasaranya S, Kladchareon N, Mahachai V, Kullavanijaya P. Feasibility and complications of endoscopic biliary drainage in patients with malignant biliary obstruction at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2002;85 Suppl 1:S48–53.

    PubMed  Google Scholar 

  5. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56:885–9.

    Article  PubMed  Google Scholar 

  6. Deviere J, Motte S, Dumonceau JM, Serruys E, Thys JP, Cremer M. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy. 1990;22:72–5.

    Article  PubMed  CAS  Google Scholar 

  7. Boender J, Nix GA, de Ridder MA, et al. Endoscopic sphincterotomy and biliary drainage in patients with cholangitis due to common bile duct stones. Am J Gastroenterol. 1995;90:233–8.

    PubMed  CAS  Google Scholar 

  8. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1–10.

    Article  PubMed  CAS  Google Scholar 

  9. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–18.

    Article  PubMed  CAS  Google Scholar 

  10. Standards ASGE of Practice Committee, Banerjee S, Shen B, Nelson DB, et al. Infection control during GI endoscopy. Gastrointest Endosc. 2008;67:781–90.

    Article  Google Scholar 

  11. Jendrzejewski JW, McAnally T, Jones SR, Katon RM. Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents. Gastroenterology. 1980;78:745–8.

    PubMed  CAS  Google Scholar 

  12. Ramirez FC, Osato MS, Graham DY, Woods KL. Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCP. J Dig Dis. 2010;11:237–43.

    PubMed  CAS  Google Scholar 

  13. Collen MJ, Hanan MR, Maher JA, Stubrin SE. Modification of endoscopic retrograde cholangiopancreatography (ERCP) septic complications by the addition of an antibiotic to the contrast media. Randomized controlled investigation. Am J Gastroenterol. 1980;74:493–6.

    PubMed  CAS  Google Scholar 

  14. Bernadino KP, Howell DA, Lawrence C, et al. Near absence of septic complications following successful therapeutic ERCP justifies selective intravenous and intracontrast use of antibiotics. Gastrointest Endosc. 2005;61:AB187.

    Google Scholar 

  15. Pugliese V, Saccomanno S, Bonelli L, Aste H. Is it useful to add gentamycin to contrast media in endoscopic retrograde cholangiopancreatography? Prospective evaluation of 330 cases. Minerva Dietol Gastroenterol. 1986;32:149–56.

    PubMed  CAS  Google Scholar 

  16. McGuire DE, Brown RD, Venu RP, et al. Intraductal gentamicin during ERCP: Does it prevent cholangitis? Gastrointest Endosc. 1995;41:406.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Science, North Kargar Ave., Shariati hospital, 14117-13135, Tehran, Iran

    Morteza Khatibian, Raziyeh Afroogh, Meghedi Chaharmahali & Rasoul Sotoudehmanesh

  2. Golestan University of Medical Sciences, Gholestan Research Center of Gastroenterology and Hepatology, 3rd floor, Shahid Nabavi clinic, 4th Azar Alley, 5th Azar St, 49177-65181, Gorgan city, Iran

    Alireza Norouzi

Authors
  1. Alireza Norouzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morteza Khatibian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raziyeh Afroogh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meghedi Chaharmahali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rasoul Sotoudehmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rasoul Sotoudehmanesh.

Additional information

ClinicalTrials.gov Identifier: NCT01148693.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norouzi, A., Khatibian, M., Afroogh, R. et al. The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial. Indian J Gastroenterol 32, 18–21 (2013). https://doi.org/10.1007/s12664-012-0208-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-012-0208-y

Keywords

Search

Navigation